{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:53:09Z","timestamp":1794631989950,"version":"4.9.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Naringenin (NAR), a flavanone abundant in citrus fruits, has shown antiproliferative effects in several cancers, including breast cancer. However, its precise molecular mechanisms remain unclear. This study integrates network pharmacology, molecular modeling, and in vitro assays to investigate the anti-breast cancer potential of NAR. Target Genes associated with both NAR and breast cancer were identified through multiple databases, yielding 62 overlapping genes, which were further analyzed via a protein\u2013protein interaction (PPI) network. Gene Ontology (GO) and KEGG pathway enrichment analyses revealed key involvement of PI3K-Akt and MAPK signaling pathways in NAR\u2019s mechanism of action. Molecular docking studies showed strong binding affinities of NAR with key targets SRC, PIK3CA, BCL2, and ESR1, findings supported by molecular dynamics (MD) simulations, which confirmed stable protein\u2013ligand interactions. Cell-based assays using MCF-7 human breast cancer cells demonstrated that NAR inhibits proliferation, induces apoptosis, reduces migration, and increases reactive oxygen species (ROS) generation. These results validate computational predictions and suggest that SRC may be a primary target mediating NAR\u2019s anticancer activity. Collectively, this study provides mechanistic insights into the anti-breast cancer action of NAR and supports its potential as a lead compound for the development of SRC-targeted breast cancer therapies.<\/jats:p>","DOI":"10.1038\/s41598-025-19931-6","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:11:11Z","timestamp":1760526671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrating in-silico and experimental validation approaches to unveil the therapeutic mechanism of naringenin against breast cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Suhail Ahmad","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basharat Ahmad","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laraibah","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umme","family":"Hani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahrah Ali Ahmed","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyaz Ali M.","family":"Osmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazima","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Nabi","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"19931_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"19931_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196608","author":"SA Mir","year":"2022","unstructured":"Mir, S. A. et al. Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.. Molecules https:\/\/doi.org\/10.3390\/molecules27196608 (2022).","journal-title":"Molecules"},{"key":"19931_CR3","unstructured":"Durgawale, T. P. et al. Chemistry, molecular mechanisms, and potential of Curcumin in cancer therapy therapeutic. 7, 452\u2013511 (2025)."},{"key":"19931_CR4","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu, E. I. & Obeagu, G. U. Breast cancer: A review of risk factors and diagnosis. Med. (Baltim). 103, e36905 (2024).","journal-title":"Med. (Baltim)."},{"key":"19931_CR5","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.glmedi.2024.100120","volume":"3","author":"JF AlSamhori","year":"2024","unstructured":"AlSamhori, J. F. et al. Artificial intelligence for breast cancer: implications for diagnosis and management. J. Med. Surg. Public. Heal. 3, 100120 (2024).","journal-title":"J. Med. Surg. Public. Heal"},{"key":"19931_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong, X. et al. Breast cancer: pathogenesis and treatments. Signal. Transduct. Target. Ther. 10, 49 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"19931_CR7","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.soi.2024.100059","volume":"1","author":"AS Baskin","year":"2024","unstructured":"Baskin, A. S., Huppert, L. A., Kelil, T., Singer, L. & Mukhtar, R. A. The neoadjuvant approach to treatment of breast cancer: multidisciplinary management to improve outcomes. Surg. Oncol. Insight. 1, 100059 (2024).","journal-title":"Surg. Oncol. Insight"},{"key":"19931_CR8","doi-asserted-by":"crossref","unstructured":"Catalano, A. et al. Multidrug resistance (MDR): A widespread phenomenon in Pharmacological therapies. Molecules 27, (2022).","DOI":"10.3390\/molecules27030616"},{"key":"19931_CR9","doi-asserted-by":"crossref","unstructured":"Esmeeta, A. et al. Plant-derived bioactive compounds in colon cancer treatment: an updated review. Biomed Pharmacother 153, (2022).","DOI":"10.1016\/j.biopha.2022.113384"},{"key":"19931_CR10","doi-asserted-by":"crossref","unstructured":"Yue, R. & Dutta, A. Computational systems biology in disease modeling and control, review and perspectives. Npj Syst. Biol. Appl 8, (2022).","DOI":"10.1038\/s41540-022-00247-4"},{"key":"19931_CR11","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1080\/07391102.2023.2234039","volume":"42","author":"I Saifi","year":"2024","unstructured":"Saifi, I. et al. Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science. J. Biomol. Struct. Dyn. 42, 6523\u20136541 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"19931_CR12","doi-asserted-by":"crossref","unstructured":"Samuel, S. M., Kubatka, P. & B\u00fcsselberg, D. Treating cancers using nature\u2019s medicine: Significance and challenges. Biomolecules 11\u00a0(2021).","DOI":"10.3390\/biom11111698"},{"key":"19931_CR13","doi-asserted-by":"crossref","unstructured":"Wang, Z., Liu, Z., Qu, J., Sun, Y. & Zhou, W. Role of natural products in tumor therapy from basic research and clinical perspectives. Acta Mater. Medica 3\u00a0(2024).","DOI":"10.15212\/AMM-2023-0050"},{"key":"19931_CR14","doi-asserted-by":"crossref","unstructured":"Elshafie, H. S., Camele, I. & Mohamed, A. A. A comprehensive review on the biological, agricultural and pharmaceutical properties of secondary metabolites Based-Plant origin. Int J. Mol. Sci\u00a0 24, (2023).","DOI":"10.3390\/ijms24043266"},{"key":"19931_CR15","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.2174\/1871520622666220421094055","volume":"22","author":"R Mohi-ud-din","year":"2022","unstructured":"Mohi-ud-din, R. et al. Recent insights into therapeutic potential of Plant-Derived flavonoids against cancer. Anticancer Agents Med. Chem. 22, 3343\u20133369 (2022).","journal-title":"Anticancer Agents Med. Chem."},{"key":"19931_CR16","first-page":"182","volume":"6","author":"S Ismaila Shina","year":"2024","unstructured":"Ismaila Shina, S. et al. Preliminary anticancer activity, antimicrobial activity, and Brine shrimp lethality bioassay fractions of ficus platyphylla del. Stem bark, adv. Adv. J. Chem. B Nat. Prod. Med. Chem. 6, 182\u2013199 (2024).","journal-title":"Adv. J. Chem. B Nat. Prod. Med. Chem."},{"key":"19931_CR17","doi-asserted-by":"crossref","unstructured":"Slika, H. et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother 146, (2022).","DOI":"10.1016\/j.biopha.2021.112442"},{"key":"19931_CR18","doi-asserted-by":"publisher","first-page":"107457","DOI":"10.1016\/j.phrs.2024.107457","volume":"209","author":"P Sitarek","year":"2024","unstructured":"Sitarek, P. et al. Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: exploring a novel mode of action. Pharmacol. Res. 209, 107457 (2024).","journal-title":"Pharmacol. Res."},{"key":"19931_CR19","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.crphar.2023.100167","volume":"6","author":"SA Mir","year":"2024","unstructured":"Mir, S. A. et al. Flavonoids as promising molecules in the cancer therapy: an insight. Curr. Res. Pharmacol. Drug Discov. 6, 100167 (2024).","journal-title":"Curr. Res. Pharmacol. Drug Discov"},{"key":"19931_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijporl.2017.07.008","volume":"100","author":"Ko\u00e7ak","year":"2017","unstructured":"Ko\u00e7ak et al. Evaluation of the possible protective role of naringenin on gentamicin-induced ototoxicity: A preliminary study. Int. J. Pediatr. Otorhinolaryngol. 100, 247\u2013253 (2017).","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"19931_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1527-3466.1999.tb00011.x","volume":"17","author":"LJ Wilcox","year":"1999","unstructured":"Wilcox, L. J., Borradaile, N. M. & Huff, M. W. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc. Drug Rev. 17, 160\u2013178 (1999).","journal-title":"Cardiovasc. Drug Rev."},{"key":"19931_CR22","first-page":"2778","volume":"6","author":"SVDS Kiran","year":"2017","unstructured":"Kiran, S. V. D. S., Rao, V., Rohini, P. & Bhagyarsee, P. Flavonoid: A review on naringenin. J. Pharmacogn Phytochem. 6, 2778\u20132783 (2017).","journal-title":"J. Pharmacogn Phytochem"},{"key":"19931_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1134\/S106816202306002X","volume":"49","author":"A Prasad","year":"2023","unstructured":"Prasad, A., Kumar, R. & Kumari, S. Recent advances in synthetic aspects of naringenin flavonoid and its bioprotective effect (A Review). Russ J. Bioorg. Chem. 49, 1177\u20131197 (2023).","journal-title":"Russ J. Bioorg. Chem."},{"key":"19931_CR24","doi-asserted-by":"crossref","unstructured":"Heidary Moghaddam, R. et al. Naringenin and naringin in cardiovascular disease prevention: A preclinical review. Eur J. Pharmacol. 887, (2020).","DOI":"10.1016\/j.ejphar.2020.173535"},{"key":"19931_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4103\/ijp.IJP_18_20","volume":"53","author":"V Nachammai","year":"2021","unstructured":"Nachammai, V., Jeyabalan, S. & Muthusamy, S. Anxiolytic effects of Silibinin and naringenin on zebrafish model: A preclinical study. Indian J. Pharmacol. 53, 457\u2013464 (2021).","journal-title":"Indian J. Pharmacol."},{"key":"19931_CR26","doi-asserted-by":"crossref","unstructured":"Ghanbari-Movahed, M., Jackson, G., Farzaei, M. H. & Bishayee, A. A systematic review of the preventive and therapeutic effects of naringin against human malignancies. Front Pharmacol. 12, (2021).","DOI":"10.3389\/fphar.2021.639840"},{"key":"19931_CR27","doi-asserted-by":"crossref","unstructured":"Issinger, O. G. & Guerra, B. Phytochemicals in cancer and their effect on the PI3K\/AKT-mediated cellular signalling. Biomed Pharmacother. 139, (2021).","DOI":"10.1016\/j.biopha.2021.111650"},{"key":"19931_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11033-021-06923-8","volume":"49","author":"S Rajabi","year":"2022","unstructured":"Rajabi, S. et al. Naringenin enhances anti-proliferation effect of 1-ferrocenyl-3-(4-methylsulfonylphenyl) propen-1-one on two different cells via targeting calmodulin signaling pathway. Mol. Biol. Rep. 49, 1027\u20131036 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"19931_CR29","doi-asserted-by":"crossref","unstructured":"Li, J., Zhao, J., Zhang, H., Liu, M. & Li, X. Naringin suppressing the PI3K\/Akt signaling pathway as a drug target in BIU87 cells. 1\u201323. 10.21203\/rs.2.21998\/v1 (2020)","DOI":"10.21203\/rs.2.21998\/v1"},{"key":"19931_CR30","first-page":"643","volume":"7","author":"SD Pawar","year":"2024","unstructured":"Pawar, S. D., Shanmugasundaram, P. & Synthesis Characterization and evaluation of anticancer activity of some 6-(Chloro\/Methoxy\/Methyl)-N-(4-Substitutedphenyl)-4-Thiomorpholinoquinazolin-3(4H)-Amine derivatives. Adv. J. Chem. Sect. A. 7, 643\u2013658 (2024).","journal-title":"Adv. J. Chem. Sect. A"},{"key":"19931_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2018.08.002","volume":"135","author":"W Zeng","year":"2018","unstructured":"Zeng, W., Jin, L., Zhang, F., Zhang, C. & Liang, W. Naringenin as a potential Immunomodulator in therapeutics. Pharmacol. Res. 135, 122\u2013126 (2018).","journal-title":"Pharmacol. Res."},{"key":"19931_CR32","doi-asserted-by":"crossref","unstructured":"Pateliya, B., Burade, V. & Goswami, S. Combining naringenin and Metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo. Eur J. Pharmacol.\u00a0891, (2021).","DOI":"10.1016\/j.ejphar.2020.173725"},{"key":"19931_CR33","first-page":"2145","volume":"7","author":"AI Setyarini","year":"2025","unstructured":"Setyarini, A. I. et al. Network Pharmacology and molecular Docking analysis of phytoestrogens in vigna unguiculata for menopause treatment via interactions with ER\u03b1, ER\u03b2, EGFR, COL1A1, and NOS3. J. Med. Pharm. Chem. Res. 7, 2145\u20132160 (2025).","journal-title":"J. Med. Pharm. Chem. Res."},{"key":"19931_CR34","doi-asserted-by":"crossref","unstructured":"He, Q. et al. Exploring the mechanism of Curcumin in the treatment of colon cancer based on network Pharmacology and molecular Docking. Front Pharmacol. 14, (2023).","DOI":"10.3389\/fphar.2023.1102581"},{"key":"19931_CR35","doi-asserted-by":"crossref","unstructured":"Gfeller, D. et al. SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42\u00a0(2014).","DOI":"10.1093\/nar\/gku293"},{"key":"19931_CR36","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W3664 (2019).","journal-title":"Nucleic Acids Res."},{"key":"19931_CR37","doi-asserted-by":"crossref","unstructured":"Kuhn, M., von Mering, C., Campillos, M., Jensen, L. J. & Bork, P. STITCH: Interaction networks of chemicals and proteins. Nucleic Acids Res. 36 (2008).","DOI":"10.1093\/nar\/gkm795"},{"key":"19931_CR38","doi-asserted-by":"crossref","unstructured":"Maitisha, G. et al. Network pharmacology-based approach to investigate the molecular targets of essential oil obtained from lavender for treating breast cancer. Heliyon 9\u00a0(2023).","DOI":"10.1016\/j.heliyon.2023.e21759"},{"key":"19931_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2274966","author":"BA Bhat","year":"2023","unstructured":"Bhat, B. A., Mir, R., Alkhanani, W., Almilaibary, M., Mir, M. A. & A. & Network Pharmacology and experimental validation for Deciphering the action mechanism of fritillaria cirrhosa D. Don constituents in suppressing breast carcinoma. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2274966 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"19931_CR40","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s12010-024-05150-8","volume":"197","author":"HP Manivannan","year":"2025","unstructured":"Manivannan, H. P., Veeraraghavan, V. P. & Francis, A. P. Prediction of Multi-targeting Pharmacological activity of bioactive compounds from medicinal plants against hepatocellular carcinoma through advanced network Pharmacology and Bioinformatics-Based investigation. Appl. Biochem. Biotechnol. 197, 2979\u20133007 (2025).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"19931_CR41","doi-asserted-by":"crossref","unstructured":"Jiang, Y. et al. Network Pharmacology-Based prediction of active ingredients and mechanisms of lamiophlomis rotata (Benth.) Kudo against rheumatoid arthritis. Front Pharmacol 10, (2019).","DOI":"10.3389\/fphar.2019.01435"},{"key":"19931_CR42","doi-asserted-by":"crossref","unstructured":"Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A. & McKusick, V. A. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33, (2005).","DOI":"10.1093\/nar\/gki033"},{"key":"19931_CR43","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gky868","volume":"47","author":"AP Davis","year":"2019","unstructured":"Davis, A. P. et al. The comparative toxicogenomics database: update 2019. Nucleic Acids Res. 47, D948\u2013D954 (2019).","journal-title":"Nucleic Acids Res."},{"key":"19931_CR44","doi-asserted-by":"crossref","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinforma. 1.30.1\u20131.30.33. (2016).","DOI":"10.1002\/cpbi.5"},{"key":"19931_CR45","doi-asserted-by":"crossref","unstructured":"Mir, W. R. et al. Network Pharmacology combined with molecular Docking and in vitro verification reveals the therapeutic potential of delphinium Roylei munz constituents on breast carcinoma. Front Pharmacol. 14\u00a0(2023).","DOI":"10.3389\/fphar.2023.1135898"},{"key":"19931_CR46","doi-asserted-by":"crossref","unstructured":"Raies, A. et al. DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Commun Biol. 5\u00a0(2022).","DOI":"10.1038\/s42003-022-04245-4"},{"key":"19931_CR47","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D., Jung, D. & Yao, R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"19931_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (United States). 19, 649\u2013658 (2017).","journal-title":"Neoplasia (United States)"},{"key":"19931_CR49","doi-asserted-by":"crossref","unstructured":"J\u00e9z\u00e9quel, P. et al. Bc-GenExMiner 4.5: New mining module computes breast cancer differential gene expression analyses. Database (2021). (2021).","DOI":"10.1093\/database\/baab007"},{"key":"19931_CR50","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"GEPIA","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45. GEPIA, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res. 45"},{"key":"19931_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi0814s24","author":"GM Morris","year":"2008","unstructured":"Morris, G. M., Huey, R. & Olson, A. J. UNIT using AutoDock for ligand-receptor Docking. Curr. Protoc. Bioinforma. https:\/\/doi.org\/10.1002\/0471250953.bi0814s24 (2008).","journal-title":"Curr. Protoc. Bioinforma"},{"key":"19931_CR52","first-page":"341","volume":"8","author":"PS Dabhade","year":"2025","unstructured":"Dabhade, P. S. et al. Diaryl Pyrazole-Chalcone hybrids as novel ER-\u03b1 modulators: docking, synthesis and Anti-Breast cancer activity evaluation. Adv. J. Chem. Sect. A. 8, 341\u2013360 (2025).","journal-title":"Adv. J. Chem. Sect. A"},{"key":"19931_CR53","doi-asserted-by":"publisher","unstructured":"Bowers, K. J. et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proc. 2006 ACM\/IEEE Conf. Supercomput. SC\u201906 (2006). https:\/\/doi.org\/10.1145\/1188455.1188544","DOI":"10.1145\/1188455.1188544"},{"key":"19931_CR54","unstructured":"Chow, E. et al. Desmond performance on a cluster of multicore processors. Simulation 1\u201314 (2008)."},{"key":"19931_CR55","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"D Shivakumar","year":"2010","unstructured":"Shivakumar, D. et al. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the Opls force field. J. Chem. Theory Comput. 6, 1509\u20131519 (2010).","journal-title":"J. Chem. Theory Comput."},{"key":"19931_CR56","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"19931_CR57","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G. J., Tobias, D. J. & Klein, M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177\u20134189 (1994).","journal-title":"J. Chem. Phys."},{"key":"19931_CR58","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","volume":"97","author":"GJ Martyna","year":"1992","unstructured":"Martyna, G. J., Klein, M. L. & Tuckerman, M. Nos\u00e9-Hoover chains: the canonical ensemble via continuous dynamics. J. Chem. Phys. 97, 2635\u20132643 (1992).","journal-title":"J. Chem. Phys."},{"key":"19931_CR59","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1063\/1.1324708","volume":"113","author":"A Toukmaji","year":"2000","unstructured":"Toukmaji, A., Sagui, C., Board, J. & Darden, T. Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions. J. Chem. Phys. 113, 10913\u201310927 (2000).","journal-title":"J. Chem. Phys."},{"key":"19931_CR60","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1021\/acs.jctc.3c00020","volume":"19","author":"AP Bhati","year":"2023","unstructured":"Bhati, A. P., Hoti, A., Potterton, A., Bieniek, M. K. & Coveney, P. V. Long time scale ensemble methods in molecular dynamics: Ligand\u2013Protein interactions and allostery in SARS-CoV-2 targets. J. Chem. Theory Comput. 19, 3359\u20133378 (2023).","journal-title":"J. Chem. Theory Comput."},{"key":"19931_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/07391102.2010.10507344","volume":"28","author":"C Koshy","year":"2010","unstructured":"Koshy, C., Parthiban, M. & Sowdhamini, R. 100 Ns molecular dynamics simulations to study intramolecular conformational changes in Bax. J. Biomol. Struct. Dyn. 28, 71\u201383 (2010).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"19931_CR62","first-page":"52","volume":"9","author":"SR Chinnakadoori","year":"2025","unstructured":"Chinnakadoori, S. R. et al. Biological exploration of ((Substituted-Phenyl-1H-Pyrazol-4-yl) Methylene) aniline derivatives as potential DPP-IV inhibitors: ADMET screening, molecular docking, and dynamics simulations. Chem. Methodol. 9, 52\u201380 (2025).","journal-title":"Chem. Methodol."},{"key":"19931_CR63","doi-asserted-by":"crossref","unstructured":"Kagami, L. P., das Neves, G. M., Timmers, L. F. S. M., Caceres, R. A. & Eifler-Lima, V. L. Geo-Measures: A PyMOL plugin for protein structure ensembles analysis. Comput Biol. Chem. 87\u00a0(2020).","DOI":"10.1016\/j.compbiolchem.2020.107322"},{"key":"19931_CR64","first-page":"1217","volume":"17","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via Inhibition of caspase-3 and \u2013\u20099 activities. Oncol. Lett. 17, 1217\u20131222 (2019).","journal-title":"Oncol. Lett."},{"key":"19931_CR65","doi-asserted-by":"crossref","unstructured":"Wang, X., Decker, C. C., Zechner, L., Krstin, S. & Wink, M. In vitro wound healing of tumor cells: Inhibition of cell migration by selected cytotoxic alkaloids. BMC Pharmacol. Toxicol. 20\u00a0(2019).","DOI":"10.1186\/s40360-018-0284-4"},{"key":"19931_CR66","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8649","author":"H Cheng","year":"2020","unstructured":"Cheng, H. et al. Naringin inhibits colorectal cancer cell growth by repressing the PI3K\/AKT\/mTOR signaling pathway. Exp. Ther. Med. https:\/\/doi.org\/10.3892\/etm.2020.8649 (2020).","journal-title":"Exp. Ther. Med."},{"key":"19931_CR67","doi-asserted-by":"crossref","unstructured":"Zhang, M. et al. Naringenin induces HepG2 cell apoptosis via ROS-Mediated JAK-2\/STAT-3 signaling pathways. Molecules 28\u00a0(2023).","DOI":"10.3390\/molecules28114506"},{"key":"19931_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.sajb.2023.12.027","volume":"165","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Investigating the potential hub genes and mechanisms of Artemisia annua L. against breast cancer based on network Pharmacology and molecular Docking. South. Afr. J. Bot. 165, 163\u2013175 (2024).","journal-title":"South. Afr. J. Bot."},{"key":"19931_CR69","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic Res. 44, 479\u2013496 (2010).","journal-title":"Free Radic Res."},{"key":"19931_CR70","doi-asserted-by":"crossref","unstructured":"Malla, R. R., Surepalli, N., Farran, B., Malhotra, S. V. & Nagaraju, G. P. Reactive oxygen species (ROS): critical roles in breast tumor microenvironment. Crit Rev. Oncol. Hematol. 160\u00a0(2021).","DOI":"10.1016\/j.critrevonc.2021.103285"},{"key":"19931_CR71","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Aranda, M. & Redondo, M. Protein kinase targets in breast cancer. Int J. Mol. Sci. 18\u00a0(2017).","DOI":"10.3390\/ijms18122543"},{"key":"19931_CR72","doi-asserted-by":"crossref","unstructured":"Choroma\u0144ska, A. et al. Modifications of plasma membrane organization in cancer cells for targeted therapy. Molecules 26\u00a0(2021).","DOI":"10.3390\/molecules26071850"},{"key":"19931_CR73","doi-asserted-by":"crossref","unstructured":"Vona, R., Iessi, E. & Matarrese, P. Role of cholesterol and lipid rafts in cancer signaling: A promising therapeutic opportunity?? Front Cell. Dev. Biol. 9\u00a0(2021).","DOI":"10.3389\/fcell.2021.622908"},{"key":"19931_CR74","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1194\/jlr.TR119000439","volume":"61","author":"F Mollinedo","year":"2020","unstructured":"Mollinedo, F. & Gajate, C. Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy. J. Lipid Res. 61, 611\u2013635 (2020).","journal-title":"J. Lipid Res."},{"key":"19931_CR75","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"19931_CR76","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"19931_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"MKEGG Kanehisa","year":"2000","unstructured":"Kanehisa, M. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"19931_CR78","first-page":"329","volume":"8","author":"O Rezaeianzadeh","year":"2024","unstructured":"Rezaeianzadeh, O. et al. Molecular docking, and anticancer evaluation of new Azo-Based sulfonamides against MCF-7 human breast cancer cell line. Chem. Methodol. 8, 329\u2013350 (2024).","journal-title":"Chem. Methodol."},{"key":"19931_CR79","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","volume":"27","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z., Jin, G., Ge, Y. & Guo, Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology 27, 1021\u20131036 (2019).","journal-title":"Inflammopharmacology"},{"key":"19931_CR80","first-page":"122","volume":"19","author":"S Noori","year":"2020","unstructured":"Noori, S., Tavirani, M. R., Deravi, N., Rabbani, M. I. M. & Zarghi, A. Naringenin enhances the anti-cancer effect of cyclophosphamide against mda-mb-231 breast cancer cells via targeting the stat3 signaling pathway. Iran. J. Pharm. Res. 19, 122\u2013133 (2020).","journal-title":"Iran. J. Pharm. Res."},{"key":"19931_CR81","doi-asserted-by":"crossref","unstructured":"Salehi, B. et al. The therapeutic potential of naringenin: A review of clinical trials. Pharmaceuticals 12 (2019).","DOI":"10.3390\/ph12010011"},{"key":"19931_CR82","doi-asserted-by":"crossref","unstructured":"Luo, J. et al. SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Res. 24, (2022).","DOI":"10.1186\/s13058-022-01596-y"},{"key":"19931_CR83","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10549-022-06637-w","volume":"196","author":"K Reinhardt","year":"2022","unstructured":"Reinhardt, K. et al. PIK3CA-mutations in breast cancer. Breast Cancer Res. Treat. 196, 483\u2013493 (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"19931_CR84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4048\/jbc.2016.19.3.252","volume":"19","author":"YH Eom","year":"2016","unstructured":"Eom, Y. H., Kim, H. S., Lee, A., Song, B. J. & Chae, B. J. BCL2 as a subtype-specific prognostic marker for breast cancer. J. Breast Cancer. 19, 252\u2013260 (2016).","journal-title":"J. Breast Cancer"},{"key":"19931_CR85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/cpt.2","volume":"97","author":"T Lorberbaum","year":"2015","unstructured":"Lorberbaum, T. et al. Systems Pharmacology augments drug safety surveillance. Clin. Pharmacol. Ther. 97, 151\u2013158 (2015).","journal-title":"Clin. Pharmacol. Ther."},{"key":"19931_CR86","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/psp4.13150","volume":"13","author":"M Alidoost","year":"2024","unstructured":"Alidoost, M. & Wilson, J. L. Preclinical side effect prediction through pathway engineering of protein interaction network models. CPT Pharmacometrics Syst. Pharmacol. 13, 1180\u20131200 (2024).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"19931_CR87","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen, D. B., Decornez, H., Furr, J. R. & Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov. 3, 935\u2013949 (2004).","journal-title":"Nat. Rev. Drug Discov"},{"key":"19931_CR88","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1111\/jcmm.16226","volume":"25","author":"X Shi","year":"2021","unstructured":"Shi, X. et al. Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro. J. Cell. Mol. Med. 25, 2563\u20132571 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"19931_CR89","doi-asserted-by":"crossref","unstructured":"Lee, C. W. et al. Naringenin induces ROS-Mediated ER stress, autophagy, and apoptosis in human osteosarcoma cell lines. Molecules. 27\u00a0(2022).","DOI":"10.3390\/molecules27020373"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19931-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19931-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19931-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:04:04Z","timestamp":1760529844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19931-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19931"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19931-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36035"}}